CDKN2B anticorps (AA 1-138)
-
- Antigène Voir toutes CDKN2B Anticorps
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Épitope
- AA 1-138
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CDKN2B est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Cyclin-dependent kinase 4 inhibitor B protein (1-138AA)
- Isotype
- IgG
- Top Product
- Discover our top product CDKN2B Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
- Autre désignation
- CDKN2B (CDKN2B Produits)
- Synonymes
- anticorps p14-INK4b, anticorps cdk4l, anticorps ink4b, anticorps mts2, anticorps p15, anticorps p15ink4b, anticorps tp15, anticorps CDK4I, anticorps INK4B, anticorps MTS2, anticorps P15, anticorps TP15, anticorps p15INK4b, anticorps AV083695, anticorps INK4b, anticorps p15(INK4b), anticorps CDKN2A, anticorps cyclin dependent kinase inhibitor 2B, anticorps Cyclin-dependent kinase 4 inhibitor B, anticorps cyclin-dependent kinase inhibitor 2B, anticorps cyclin-dependent kinase inhibitor 2B L homeolog, anticorps cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), anticorps CDKN2B, anticorps cdn2b, anticorps cdkn2b, anticorps cdkn2b.L, anticorps Cdkn2b
- Sujet
-
Background: Interacts strongly with CDK4 and CDK6. Potent inhibitor. Potential effector of TGF-beta induced cell cycle arrest.
Aliases: CDK inhibitory protein antibody, CDK4B Inhibitor antibody, Cdkn2b antibody, CDN2B_HUMAN antibody, Cyclin dependent kinase 4 inhibitor B antibody, Cyclin Dependent Kinase Inhibitor 2B antibody, Cyclin dependent kinase inhibitor 2B p15 inhibits CDK4 antibody, Cyclin dependent kinases 4 and 6 binding protein antibody, Cyclin-dependent kinase 4 inhibitor B antibody, INK4B antibody, MTS 2 antibody, MTS-2 antibody, MTS2 antibody, Multiple tumor suppressor 2 antibody, Multiple Tumor Supressor 2 antibody, OTTHUMP00000021154 antibody, OTTHUMP00000021155 antibody, p14 CDK inhibitor antibody, p14 INK4b antibody, p14-INK4b antibody, P15 antibody, p15 CDK inhibitor antibody, p15 inhibits CDK4 antibody, p15 INK4b antibody, p15-INK4b antibody, p15INK4B antibody, TP 15 antibody, TP15 antibody
- UniProt
- P42772
- Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases
-